Contact Lens Discomfort Clinical Trial
Official title:
A Controlled Phase 2 Study for Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel
This study compares contact lens comfortable wear duration, and signs and symptoms of contact lens discomfort, test versus control.
The clinical hypothesis is that CLM2 topical gel applied dermally on the forehead twice daily will be more effective than placebo (a) in reducing or eliminating ocular discomfort associated with contact lens wear, (b) prolong hours of comfortable wear, (c) prolong total hours of contact lens wear, (d) improve ease of insertion and removal of contact lens, and ( c) reduces friction between cornea/lens and lens/eyelid, without use of artificial eye drops or gels. One mechanism supporting this hypothesis is preliminary evidence of increased meibum secretion following CLM2 topical gel application. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03682809 -
Evaluation of Systane Complete for the Treatment of Contact Lens Discomfort
|
Phase 4 | |
Completed |
NCT05416528 -
Chinese Translation and Validation of the 8-item Contact Lens Dry Eye Questionnaire (CLDEQ-8)
|
||
Completed |
NCT05548491 -
Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Contact Lens Discomfort (CLD)
|
Phase 2 | |
Completed |
NCT03311204 -
The Effect of Eyelid Margin Debridement on Contact Lens Discomfort
|
N/A | |
Active, not recruiting |
NCT03652337 -
Meibomian Gland Dysfunction Management
|
N/A | |
Not yet recruiting |
NCT05801991 -
Neurolens and Contact Lens Discomfort
|
N/A | |
Completed |
NCT02848222 -
Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers
|
N/A | |
Completed |
NCT03686878 -
Lifitegrast 5% Ophthalmic Solution and Contact Lens Dryness
|
Phase 4 |